SCHEMBL8791127

SCHEMBL8791127

CCN1C(=O)c2cccnc2N(C)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.48
ALDH1A1 P00352 9/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 1/20 0.47
CASP1 P29466 1/20 0.47
MPI P34949 1/20 0.47
CACNA1B Q00975 1/20 0.47
APBA1 Q02410 1/20 0.47
MAPT P10636 3/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
DRD2 P14416 1/20 0.46
DRD1 P21728 1/20 0.46
SLC6A2 P23975 1/20 0.46
HTR2A P28223 1/20 0.46
SLC6A4 P31645 1/20 0.46
HTR7 P34969 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790527 0.90 DRD2 (0.48) BRD4ALDH1A1MAPTLMNACHRM2
SCHEMBL8791051 0.90 BRD4 (0.51) BRD4ALDH1A1SMN1; SMN2HPGDCASP1
SCHEMBL9370046 0.89 BRD4 (0.48) BRD4ALDH1A1SMN1; SMN2HPGDCASP1
SCHEMBL8789567 0.89 BRD4 (0.46) BRD4ALDH1A1MAPTLMNACHRM2
SCHEMBL8790087 0.88 ALDH1A1 (0.51) ALDH1A1MAPTLMNACHRM2HTR1A
SCHEMBL8790761 0.85 TTR (0.50) BRD4ALDH1A1DRD2HTR6HSD17B10
SCHEMBL8301100 0.84 ALDH1A1 (0.50) BRD4ALDH1A1SMN1; SMN2HPGDCASP1
SCHEMBL9369777 0.82 BRD4 (0.50) BRD4ALDH1A1SMN1; SMN2HPGDCASP1
SCHEMBL8791314 0.82 BRD4 (0.47) BRD4ALDH1A1SMN1; SMN2HPGDCASP1
SCHEMBL8790016 0.82 BRD4 (0.47) BRD4ALDH1A1MAPTLMNACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393604-B1 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMA (US) 1997-12-29 EP claimed
US-5571809-A The treatment of HIV-1 infection using certain pyridodiazepines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-11-05 US claimed
EP-0393604-A2 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-10-24 EP claimed
EP-0393604-B1 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMA (US) 1997-12-29 EP disclosed
US-5571809-A The treatment of HIV-1 infection using certain pyridodiazepines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-11-05 US disclosed
EP-0393604-A2 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-10-24 EP disclosed